PL373543A1 - Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy - Google Patents

Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy

Info

Publication number: PL373543A1
Authority: PL; Poland
Prior art keywords: well; application; compound containing; human insulin; pharmaceutical compound
Prior art date: 2005-03-10

Application number

PL373543A

Other languages

English (en)

Inventor

Piotr Borowicz

Jerzy Mikołajczyk

Monika Bogiel

Henryk Klukowski

Anna Krejer

Original Assignee

Instytut Biotechnologii i Antybiotyków

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-10

Filing date

2005-03-10

Publication date

2006-09-18

2005-03-10 Application filed by Instytut Biotechnologii i Antybiotyków filed Critical Instytut Biotechnologii i Antybiotyków

2005-03-10 Priority to PL373543A priority Critical patent/PL373543A1/pl

2006-03-09 Priority to PCT/PL2006/000016 priority patent/WO2006096079A2/en

2006-09-18 Publication of PL373543A1 publication Critical patent/PL373543A1/pl

Links

101000976075 Homo sapiens Insulin Proteins 0.000 title 1
230000001851 biosynthetic effect Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
206010012601 diabetes mellitus Diseases 0.000 title 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Diabetes (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Endocrinology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

PL373543A 2005-03-10 2005-03-10 Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy PL373543A1 (pl)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
PL373543A PL373543A1 (pl)	2005-03-10	2005-03-10	Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy
PCT/PL2006/000016 WO2006096079A2 (en)	2005-03-10	2006-03-09	Pharmaceutical composition comprising a biosynthetic analog of human insulin, and its use in the treatment of diabetes mellitus.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL373543A PL373543A1 (pl)	2005-03-10	2005-03-10	Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy

Publications (1)

Publication Number	Publication Date
PL373543A1 true PL373543A1 (pl)	2006-09-18

Family

ID=36953765

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL373543A PL373543A1 (pl)	2005-03-10	2005-03-10	Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy

Country Status (2)

Country	Link
PL (1)	PL373543A1 (pl)
WO (1)	WO2006096079A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL219335B1 (pl)	2008-07-04	2015-04-30	Inst Biotechnologii I Antybiotyków	Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, jej zastosowanie oraz zawierająca ją kompozycja farmaceutyczna
PL222975B1 (pl)	2012-05-23	2016-09-30	Inst Biotechnologii I Antybiotyków	Analog insuliny lub jego farmaceutycznie dopuszczalna sól, kompozycja farmaceutyczna o przedłużonym działaniu terapeutycznym oraz zastosowanie analogu insuliny

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3327709A1 (de) *	1983-07-29	1985-02-07	Hoechst Ag, 6230 Frankfurt	Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DE3844211A1 (de) *	1988-12-29	1990-07-05	Hoechst Ag	Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US6451970B1 (en) *	1996-02-21	2002-09-17	Novo Nordisk A/S	Peptide derivatives
US6531448B1 (en) *	1997-12-23	2003-03-11	Eli Lilly And Company	Insoluble compositions for controlling blood glucose

2005
- 2005-03-10 PL PL373543A patent/PL373543A1/pl not_active Application Discontinuation
2006
- 2006-03-09 WO PCT/PL2006/000016 patent/WO2006096079A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2006096079A2 (en)	2006-09-14
WO2006096079A3 (en)	2007-03-22

Similar Documents

Publication	Publication Date	Title
IL184838A0 (en)	2007-12-03	Spiroketal derivative and use thereof as diabetic medicine
IL185277A0 (en)	2008-02-09	Pharmaceutical compositions containing roflumilast for the treatment of diabetes
IL185462A0 (en)	2008-01-06	New pharmaceutical compositions useful in the treatment of pain
IL195947A (en)	2013-07-31	Manicured cyclic compounds and pharmaceutical preparations containing them for use @ for prevention @ and treatment @ for diabetes
WO2007128817A3 (en)	2008-03-06	Insulin derivative
IL185761A0 (en)	2008-01-20	Pharmaceutical compositions for treating diabetes
TWI350751B (en)	2011-10-21	Pharmaceutical compositions for treating diabetes
PL381247A1 (pl)	2007-05-14	Skondensowana pochodna heterocykliczna, zawierająca ją kompozycja lecznicza, oraz jej zastosowanie lecznicze
IL196869A0 (en)	2009-11-18	A pharmaceutical composition containing a hexahydrophenanthridin-2-ol derivative in combination with another active ingredient for treatment of diabetes mellitus
IL225198A (en)	2016-02-29	Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes
GB0522311D0 (en)	2005-12-07	Pharmaceutical compositions for the treatment of pain
IL196586A0 (en)	2009-11-18	Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes
ZA200506941B (en)	2006-05-31	Improvements in or relating to drive mechanisms suitable for use in drug delivery devices
ZA200708327B (en)	2009-09-30	Reduction of postoperative pain medication
EP2070540A4 (en)	2009-11-11	DRUG COMPOSITION FOR THE TREATMENT OF DIABETES TYPE 2 AND CHRONIC NEOPATHY
ZA201000990B (en)	2011-04-28	Herbal formulations for controlling blood glucose levels in patients with diabetes
EP2322207A4 (en)	2012-04-18	OXYGEN TRANSMITTING BLOOD SUBSTITUTE AND PHARMACEUTICAL COMPOSITION (VARIANTS)
IL184697A (en)	2014-02-27	Diclofenac Injection Composition, Process for its Preparation and Use for Medication and Pain Relief and / or Inflammation
EP1894588A4 (en)	2012-05-30	NEEDLE FOR MEDICAL TREATMENT
LT2918286T (lt)	2020-04-10	Farmacinis preparatas, kurio sudėtyje yra kristalinės ir taip pat ištirpintos formos insulino
PL373543A1 (pl)	2006-09-18	Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy
EP1792620A4 (en)	2010-12-15	MEDICAL COMPOSITION WITH AN AGENT AGAINST DIABETES
ZA200706022B (en)	2008-11-26	Spiroketal derivatives and use thereof as diabetic medicine
EP2066171A4 (en)	2010-12-08	ADMINISTERING A TREATMENT SUBSTANCE TO POROUS ELEMENTS
ZA201005394B (en)	2014-01-29	15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone derivative,use thereof,and medicament containing said derivative

Legal Events

Date	Code	Title	Description
2010-03-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)